• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

pSivida Corp. - Articles and news items

Medidur

EC grants orphan designation to pSivida’s Medidur

Industry news / 3 May 2016 / Victoria White, Digital Content Producer

The EC has granted orphan medicinal product designation to Medidur for the treatment of chronic non-infectious uveitis of the posterior of the eye…

medidur

pSivida announces positive top-line results from investigator-sponsored Phase II study of Medidur in uveitis

Industry news / 13 July 2015 / Victoria White

pSivida has announced positive top-line results from a Phase II investigator-sponsored study of Medidur for uveitis affecting the posterior of the eye…

raxone

pSivida announces positive safety data from Phase III trial of Medidur

Industry news / 19 May 2015 / Victoria White

pSivida has announced positive safety data from its ongoing assessment of safety data from its Phase III clinical trial of Medidur for posterior uveitis…

Medidur

pSivida completes targeted enrollment of Phase III trial of Medidur for posterior uveitis

Industry news / 2 April 2015 / Victoria White

pSivida has announced the completion of the targeted enrollment of 120 patients in its pivotal Phase III clinical trial of Medidur for posterior uveitis…

pSivida logo

pSivida announces ILUVIEN® marketing authorisation in Germany

Industry news, News / 27 July 2012 / pSivida Corp.

For the treatment of vision impairment associated with chronic diabetic macular edema…

pSivida logo

pSivida announces resubmission of New Drug Application for ILUVIEN®

Industry news, News / 13 May 2011 / pSivida Corp.

A New Drug Application for the investigational drug ILUVIEN® for the treatment of diabetic macular edema (DME) has been resubmitted…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionWATCH NOW
+ +